EY has announced plans to expand the current Health Outcomes Assessment platform through a collaboration with Sensyne Health and Guardtime. The platform will help provide an end-to-end solution for outcomes-based contracting; an approach that ties the payment of medicines to the achievement of specific clinical and patient satisfaction benchmarks and efficiency improvements in patient treatment pathways.
Through the planned collaboration, Sensyne Health will be engaged to add clinical artificial intelligence (AI) and Guardtime will add blockchain technologies to help enable the platform to scale faster, leading to fairer reimbursement and access to novel treatments for patients.
The collaboration will aim to solve one of health care's biggest challenges – accurate and fair patient reimbursement against the actual health outcome provided by health care providers and drug manufacturers.
Under the arrangement, EY teams will bring independent contract assessment, contract management and automated business process experience to allow pharmaceutical companies and health care providers to share data and help manage real-world outcomes-based contracts at scale.
